Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in South America has been on the rise in recent years, with more and more people seeking immunization against preventable diseases.
Customer preferences: Customers in South America are becoming increasingly aware of the importance of vaccination in preventing the spread of diseases. This has led to a growing demand for vaccines, particularly for diseases such as influenza, measles, and HPV. In addition, there is also a rising demand for travel vaccines as more people travel both within and outside the region.
Trends in the market: One of the key trends in the vaccines market in South America is the increasing adoption of new technologies and innovations. This has led to the development of new vaccines that are more effective and have fewer side effects. Another trend is the growing use of combination vaccines, which offer protection against multiple diseases in a single shot. This has become particularly popular in countries with limited healthcare resources.
Local special circumstances: The vaccines market in South America is characterized by a high degree of fragmentation, with many small and medium-sized players operating in the region. This has led to intense competition and price pressures, particularly in countries with weaker healthcare systems. In addition, there are also significant differences in vaccination rates between countries, with some countries lagging behind others in terms of immunization coverage.
Underlying macroeconomic factors: The vaccines market in South America is influenced by a range of macroeconomic factors, including government policies, healthcare spending, and disease outbreaks. In many countries, governments play a key role in vaccine procurement and distribution, which can have a significant impact on market dynamics. Healthcare spending also plays a critical role, particularly in countries with limited resources. Finally, disease outbreaks can have a major impact on vaccine demand, as seen in recent years with outbreaks of diseases such as Zika and yellow fever.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
